Growth through profiles TIBBIYAH is a diversified healthcare holding with a long history in Saudi Arabia, recently expanding leadership and corporate governance. The fresh appointments of a new Chairman and CEO in 2026 suggest a strategic push to transform the business and accelerate organic growth, presenting an opportunity to offer scalable healthcare technologies, integration services, and managed procurement capabilities aligned to their expansion plans.

Genomics Partnership Strategic collaboration with BGI Genomics to launch Genalive, a state-of-the-art clinical genomics laboratory in Saudi Arabia, highlights a growing demand for advanced diagnostics and sequencing services. Sales opportunities exist in next-generation sequencing equipment, bioinformatics platforms, LIS/EMR integration, and genomic data management solutions.

Strategic acquisitions Recent acquisition of Alhammad Medical Services signals aggressive market consolidation and expansion of service capabilities. This creates cross-sell potential for integrated medical equipment, turnkey hospital solutions, and service contracts across a broader client base in the KSA healthcare sector.

Joint ventures leverage The 50-50 Philips Healthcare Saudi Arabia JV and the NephroPlus collaboration indicate a strong appetite for international partnerships to standardize high-end equipment, dialysis services, and patient care infrastructures. Opportunities exist to provide premium equipment, remote monitoring, service-level agreements, and turnkey installation for large hospital networks.

Public growth signals TIBBIYAH’s public listing and Nomu exposure, plus a revenue range of 100–250 million USD, suggests a mature but expanding mid-market footprint with potential procurement and cloud-based IT modernization needs. Ideal targets include ERP optimization, data security, cloud-enabled clinical workflows, and scalable maintenance programs for a growing national footprint.